PAN Launches Financial Assistance Program for Mantle Cell Lymphoma Patients
Washington, DC, June 11, 2013 – Patient Access Network (PAN) Foundation has launched its newest financial assistance program, providing new hope to patients being treated for Mantle Cell Lymphoma (MCL). This program marks the Foundation’s 11th new program in 2013.
“Patients with Mantle Cell Lymphoma have often found themselves unable to qualify for desperately needed financial assistance for their life-saving medications,” explained Patrick McKercher, PAN President. “MCL patients can now depend on a trusted resource for co-pay assistance and will be put on the fast track to therapy through our best-in-class financial assistance program.”
Qualifying patients are eligible to receive $10,000 per year to cover costs associated with their specialty medications. Patients must have Medicare insurance, must have a household income less than or equal to 500% of the Federal Poverty Level and must reside and receive treatment in the United States.
Click Here to learn more about PAN’s Mantle Cell Lymphoma program.
About Mantle Cell Lymphoma
Mantle cell lymphoma (MCL) results from a malignant transformation of a B lymphocyte in the outer edge of a lymph node follicle (the mantle zone). The transformed B lymphocyte grows in an uncontrolled way and the accumulated lymphoma cells form tumors in lymph nodes, which leads to their enlargement. The MCL cells can enter the lymphatic channels and the blood, and can spread to other lymph nodes or tissues, such as the marrow, liver and gastrointestinal tract. There are about 66,360 new cases of NHL in the United States each year. MCL patients represent about 6 percent of all new cases of NHL per year. MCL occurs more frequently in older adults—the average age-range at diagnosis is the mid-60s; it is more often diagnosed in males than in females; and white males and females are at a higher risk than black males and females for an MCL diagnosis.
About the PAN Foundation
Patient Access Network Foundation is dedicated to providing help and hope to patients who would otherwise be unable to afford high-cost specialty medications. PAN envisions a society in which every individual can access needed medical care, offering hope for a healthy tomorrow. PAN provides assistance through nearly 50 disease-specific programs designed to help patients being treated for certain cancers, chronic illnesses, and rare diseases. Through our streamlined application process and state of the art online tools, we are able to ensure that patients are put on the fast track to therapy.